Senior insider sale
KESTRA MEDICAL TECHNOLOGIES, LTD. — senior position signals high conviction
$98.5K
3.91K shares
What this filing means
LADONE MARY KAY plans to sell 3.91K shares of KESTRA MEDICAL TECHNOLOGIES, LTD. valued at approximately $98.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/8/2026ACC: 0001964306-26-000429
Director
Since Mar 2025
3.91K
Shares to sell
$98.5K
Approx. market value
3.91K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit awards
Granted as part of issuer equity compensation plan
9/4/2026
3.91KTotal acquired3.91K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/4/2026 | Vesting of restricted stock unit awards Granted as part of issuer equity compensation plan | 3.91K | — |
| Total | 3.91K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.91K
Market value
$98.5K
9/8/2026
Total
Units
3.91K
Value
$98.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/8/2026 | 3.91K | $98.5K | NASDAQ | Planned |
| Total | 3.91K | $98.5K | ||